News in brief - August 2014

Other new launches, licence changes and updates relevant to general practice.

Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
  • Janssen-Cilag has launched Sylvant (siltuximab) for the treatment of multicentric Castleman's disease in adults who are HIV-negative and human herpesvirus-8 negative.
  • The cold sore cream Fenistil (penciclovir) has been reclassified from a P medicine to a GSL.
  • Arzerra (ofatumumab) is now indicated in combination with chlorambucil or bendamustine for the treatment of chronic lymphocytic leukaemia in previously untreated patients ineligible for fludarabine-based therapy.

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Review patients soon after starting opioids, says updated chronic pain guidance

Review patients soon after starting opioids, says updated chronic pain guidance

Revised chronic pain guidance from the Scottish Intercollegiate...

Contraceptive shortages reported by manufacturers

Contraceptive shortages reported by manufacturers

Shortages of several contraceptives, including combined,...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: FemSeven Sequi and FemSeven Conti.
Use...